Novo Nordisk A/s Stock Performance
as on September 16, 2025 at 9:40 pm IST
Day's Low
Day's High
$56.63$57.44
1.26%
Downside
0.16%
Upside
52 Week's Low
52 Week's High
$45.05$138.2221.45%
Downside
141.01%
Upside
Novo Nordisk A/s share price movements today
- Previous Close
- $55.62
- Open
- $57.10
- Volume
- 10.9M
- Day's Low - High
- $56.63 - $57.44
- 52 Week Low - High
- $45.05 - $138.22
Novo Nordisk A/s Historical Returns
- 1 Month Return
- + 6.12 %
- 3 Month Return
- -27.78 %
- 1 Year Return
- -59.37 %
- 3 Year Return
- + 9.68 %
- 5 Year Return
- + 63.68 %
Novo Nordisk A/s Stock Fundamentals & Key Indicators
Check Novo Nordisk A/s market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$240.9B
EPS (TTM)
24.4348
Dividend Yield
1.05%
Quarterly Earnings Growth YOY
0.33%
PE Ratio (TTM)
14.03
Industry PE ratio
17.391111111111112
P/B Ratio
14.0332
PEG Ratio
1.377
EBITDA
159.3B
Revenue (TTM)
311.9B
Profit Margin
35.61%
Return On Equity TTM
79.17%
Novo Nordisk A/s Stock Valuation
Track how Novo Nordisk A/s P/E has moved over time to understand its valuation trends.
Novo Nordisk A/s in the last 5 years
Lowest (2.73x)
June 30, 2025
Today (14.03x)
September 16, 2025
Industry (17.39x)
September 16, 2025
Highest (45.23x)
June 30, 2024
Today’s Price to Earnings Ratio: 14.03x
Novo Nordisk A/s vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Novo Nordisk A/s with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $240.9B | 63.68% | 14.03 | 35.61% | |
| BUY | $677.2B | 395.62% | 49.26 | 25.91% | |
| BUY | $385.7B | 142.38% | 104.12 | 6.45% | |
| BUY | $428.8B | 19.54% | 19.05 | 25.00% | |
| BUY | $206.8B | -5.32% | 12.76 | 25.79% |
Stock Returns calculator for Novo Nordisk A/s Stock including INR - Dollar returns
The Novo Nordisk A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novo Nordisk A/s investment value today
Current value as on today
₹46,759
Returns
Returns from Novo Nordisk A/s Stock
Dollar Returns*
₹4,867 (+4.87%)
Analyst Recommendation on Novo Nordisk A/s Stock
Based on 32 analysts
62.50%
Buy
31.25%
Hold
6.25%
Sell
Based on 32 analysts, 62.5% of analysts recommend a 'BUY' rating for Novo Nordisk A/s. Average target price of $64
Novo Nordisk A/s Share Price Target
Get share price movements and forecasts by analysts on Novo Nordisk A/s.
What analysts predicted
10.39%UPSIDE
Target Price
$64
Current Price
$57.35
Analyzed by
32 Analysts
Target
$64.00
Novo Nordisk A/s target price $64, a slight upside of 10.39% compared to current price of $57.35. According to 32 analysts rating.
Novo Nordisk A/s Stock's Interest Amongst Investors
Investment in Novo Nordisk A/s Shares on INDmoney has dropped by -49.78% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Novo Nordisk A/s Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Novo Nordisk A/s Quarterly Profit & Loss
All numbers in Millions USD
Novo Nordisk A/s Annual Profit & Loss
All numbers in Millions USD
Novo Nordisk A/s Quarterly Cash Flow
All numbers in Millions USD
Novo Nordisk A/s Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Novo Nordisk A/s Stock
Check out the Mutual Funds with significant holdings in Novo Nordisk A/s.
Funds | Holdings | Shares Held |
|---|---|---|
 DSP Value Fund Direct Plan Growth | 1.16914% | 25065 |
DSP Multi Asset Allocation Fund Direct Growth | 1.02944% | 80484 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 1.52011% | 5007 |
 Axis Innovation Fund Direct Growth | 0.24942% | 5887 |
Global Institutional Holdings in Novo Nordisk A/s
Novo Nordisk A/s News & Key Events
Today's Timeline - 16 September
Tue, 03:30 PM
-Cagrilintide shows significant weight loss and tolerability in phase 3 trial results.
Tue, 03:57 PM
-Novo Nordisk announces 9,000 job cuts as part of a cost-saving initiative amid competition with Eli Lilly.
Tue, 04:56 PM
-Novo Nordisk flags promising late-stage trial results for Cagrilintide, a next-generation obesity treatment.
Today's Timeline - 16 September
Tue, 05:03 PM
-Novo Nordisk secures EMA approval for Rybelsus label update reflecting cardiovascular benefits.
Tue, 05:37 PM
-Shares rose 3% after Cagrilintide showed 11.8% weight loss in patients after 68 weeks.
Tue, 05:46 PM
-Rothschild & Co Redburn upgrades Novo Nordisk to buy, citing attractive valuation.
Today's Timeline - 16 September
Tue, 06:09 PM
-Survey shows Wegovy improves mental well-being for 67% of users, but shares dropped nearly 60% over the past year.
Tue, 07:51 PM
-Novo Nordisk seeks FDA approval for high-dose Wegovy to compete with Eli Lilly's Zepbound.
Insights on Novo Nordisk A/s
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Abbvie Inc has given 11.2% return, outperforming this stock by 70.6%
- NO EFFECT
Against Peers
In the last 3 years, Eli Lilly And Company has given 51.1% return, outperforming this stock by 41.4%
NEGATIVE IMPACTRevenue Fall
Novo Nordisk A/S has experienced a decline in revenue over the last three quarters. The revenue has decreased from $85.68 billion to $76.85 billion, representing an average decline of 5.2% per quarter.
- NEGATIVE IMPACT
Profit Down
Novo Nordisk A/S has experienced a decline in net profit over the last two quarters. Specifically, their net profit decreased from $29.03 billion to $26.50 billion, which represents an average decrease of about 8.7% per quarter.
- NEGATIVE IMPACT
Price Dip
In the last 3 months, NVO stock has moved down by -27.8%
About Novo Nordisk A/s
| Organisation | Novo Nordisk A/s |
| Headquarters | Novo Alle 1, Bagsvaerd, Denmark, 2880 |
| Industry | Health Technology |
| CEO | Mr. Maziar Mike Doustdar |
| E-voting on shares | Click here to vote |
Key Management of Novo Nordisk A/s
Name | Title |
|---|---|
Mr. John F. Kuckelman | Group General Counsel |
Mr. Henrik Ehlers Wulff | Executive VP of CMC & Product Supply and Member of the Management Board |
Mr. Ludovic Helfgott | Executive VP of Product & Portfolio Strategy and Member of Management Board |
Dr. Martin Holst Lange | EVP of R&D, CSO and Member of the Management Board |
Mr. David S. Moore | Executive VP of US Operations & Member of Management Board |
Ms. Thilde Hummel Bogebjerg | Executive VP of Quality, IT & Environmental Affairs and Member of Management Board |
Mr. Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board |
Mr. Maziar Mike Doustdar | President, CEO & Member of the Management Board |
Ms. Tania Sabroe | EVP of People, Organisation and Corporate Affairs & Member of Management Board |
Jacob Martin Wiborg Rode | Head of Investor Relations |
FAQs
What is Novo Nordisk A/s share price today?
Novo Nordisk A/s share price today is $57.35 as on . Novo Nordisk A/s share today touched a day high of $57.44 and a low of $56.63.
What is the 52 week high and 52 week low for Novo Nordisk A/s share?
Novo Nordisk A/s share touched a 52 week high of $138.22 on and a 52 week low of $45.05 on . Novo Nordisk A/s stock price today i.e. is trending at $57.35,which is 58.51% down from its 52 week high and 27.30% up from its 52 week low.
What is Novo Nordisk A/s's market capitalisation today?
Novo Nordisk A/s market capitalisation is $0.24T as on .
How to invest in Novo Nordisk A/s Stock (NVO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Novo Nordisk A/s on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novo Nordisk A/s Shares that will get you 0.0262 shares as per Novo Nordisk A/s share price of $57.35 per share as on September 16, 2025 at 9:40 pm IST.
What is the minimum amount required to buy Novo Nordisk A/s Stock (NVO) from India?
Indian investors can start investing in Novo Nordisk A/s (NVO) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Novo Nordisk A/s stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novo Nordisk A/s share’s latest price of $57.35 as on September 16, 2025 at 9:40 pm IST, you will get 0.1744 shares of Novo Nordisk A/s. Learn more about
fractional shares .
What are the returns that Novo Nordisk A/s has given to Indian investors in the last 5 years?
Novo Nordisk A/s stock has given 63.68% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?